[1]
S. Ahmadian Davoudi, M. Hashemi, M. Heshmati, A. Jebali, and M. Entezari, “Development and Experimental Evaluation of a Multi-Epitope Nanolipopeptide Platform Targeting PD-1, PD-L1, and HER2 for Gastric Adenocarcinoma Immunotherapy”, Arch Adv Biosci, vol. 17, no. 1, pp. 1–15, Sep. 2026.